Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Cancers|February 25, 2022
The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing ApproachBénedith Oben, Charlotte Cosemans, Ellen Geerdens, et al.
Cancers|October 13, 2021
Transcriptomic Analysis in Multiple Myeloma and Primary Plasma Cell Leukemia with t(11;14) Reveals Different Expression Patterns with Biological Implications in Venetoclax SensitivityKatia Todoerti, Elisa Taiana, Noemi Puccio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2012
Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptorsCarlo Visco, Francesco Maura, Giacomo Tuana, et al.
Leukemia Research|September 27, 2018
Global methylation patterns in primary plasma cell leukemiaKatia Todoerti, Giovanni Calice, Stefania Trino, et al.
Oncotarget|January 12, 2017
Clonal evolution in therapy-related neoplasmsEmiliano Fabiani, Giulia Falconi, Luana Fianchi, et al.
Cancers|May 28, 2020
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering MyelomaMartina Manzoni, Valentina Marchica, Paola Storti, et al.
European Journal of Haematology|April 23, 2010
The clinical and biological features of a series of immunophenotypic variant of B-CLLLilla Cro, Andrea Ferrario, Marta Lionetti, et al.
Oncotarget|June 20, 2015
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activationMarta Lionetti, Marzia Barbieri, Katia Todoerti, et al.
Annals of Hematology|April 20, 2023
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohortDaniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, et al.
Oncotarget|March 13, 2013
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myelomaMaria Teresa Di Martino, Annamaria Gullà, Maria Eugenia Gallo Cantafio, et al.
Pageof 7